N-[1-(1,3-benzothiazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline;N-(1-pyrazin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyridin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyrimidin-2-ylsulfanylpropyl)-4-(trifluoromethyl)aniline;N-[1-(1,3-thiazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline
C107H101F21N16O6S5 — CID 158005238
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-(1,3-benzothiazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline;N-(1-pyrazin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyridin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyrimidin-2-ylsulfanylpropyl)-4-(trifluoromethyl)aniline;N-[1-(1,3-thiazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline
N-[1-(1,3-benzothiazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline;N-(1-pyrazin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyridin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyrimidin-2-ylsulfanylpropyl)-4-(trifluoromethyl)aniline;N-[1-(1,3-thiazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline (PubChem CID 158005238) has the molecular formula C107H101F21N16O6S5 and a molecular weight of 2266.38 g/mol. Its IUPAC name is N-[1-(1,3-benzothiazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline;N-(1-pyrazin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyridin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyrimidin-2-ylsulfanylpropyl)-4-(trifluoromethyl)aniline;N-[1-(1,3-thiazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline.
Molecular Properties
| Compound Name | N-[1-(1,3-benzothiazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline;N-(1-pyrazin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyridin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyrimidin-2-ylsulfanylpropyl)-4-(trifluoromethyl)aniline;N-[1-(1,3-thiazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline |
|---|---|
| PubChem CID | 158005238 |
| Molecular Formula | C107H101F21N16O6S5 |
| Molecular Weight | 2266.38 g/mol |
| Exact Mass | 2264.64 |
| IUPAC Name | N-[1-(1,3-benzothiazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-yloxy)propyl]-4-(trifluoromethyl)aniline;N-[1-(1,3-benzoxazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline;N-(1-pyrazin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyridin-2-yloxypropyl)-4-(trifluoromethyl)aniline;N-(1-pyrimidin-2-ylsulfanylpropyl)-4-(trifluoromethyl)aniline;N-[1-(1,3-thiazol-2-ylsulfanyl)propyl]-4-(trifluoromethyl)aniline |
| SMILES | CCC(Nc1ccc(C(F)(F)F)cc1)Oc1ccccn1.CCC(Nc1ccc(C(F)(F)F)cc1)Oc1cnccn1.CCC(Nc1ccc(C(F)(F)F)cc1)Oc1nc2ccccc2o1.CCC(Nc1ccc(C(F)(F)F)cc1)Oc1nc2ccccc2s1.CCC(Nc1ccc(C(F)(F)F)cc1)Sc1nc2ccccc2o1.CCC(Nc1ccc(C(F)(F)F)cc1)Sc1ncccn1.CCC(Nc1ccc(C(F)(F)F)cc1)Sc1nccs1 |
| InChI | InChI=1S/C17H15F3N2O2.2C17H15F3N2OS.C15H15F3N2O.C14H14F3N3O.C14H14F3N3S.C13H13F3N2S2/c1-2-15(21-12-9-7-11(8-10-12)17(18,19)20)24-16-22-13-5-3-4-6-14(13)23-16;1-2-15(21-12-9-7-11(8-10-12)17(18,19)20)23-16-22-13-5-3-4-6-14(13)24-16;1-2-15(21-12-9-7-11(8-10-12)17(18,19)20)24-16-22-13-5-3-4-6-14(13)23-16;1-2-13(21-14-5-3-4-10-19-14)20-12-8-6-11(7-9-12)15(16,17)18;1-2-12(21-13-9-18-7-8-19-13)20-11-5-3-10(4-6-11)14(15,16)17;1-2-12(21-13-18-8-3-9-19-13)20-11-6-4-10(5-7-11)14(15,16)17;1-2-11(20-12-17-7-8-19-12)18-10-5-3-9(4-6-10)13(14,15)16/h3*3-10,15,21H,2H2,1H3;3-10,13,20H,2H2,1H3;2*3-9,12,20H,2H2,1H3;3-8,11,18H,2H2,1H3 |
| InChIKey | FEFFFWLCTMOFDY-UHFFFAOYSA-N |
| XLogP | 33.99 |
| TPSA | 263.42 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 155 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2266.38 |
| LogP ≤ 5 | 33.99 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 27 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'thiazol_SC_A(3)', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158005238 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.